Evidence map›Paper›PMID 30376915›Full record

Observational studyEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2018

Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010/11 to 2015/16.

Pere Godoy, Arantxa Romero, Núria Soldevila, Nuria Torner, Mireia Jané, Ana Martínez, Joan A Caylà, Cristina Rius, Angela Domínguez, Working Group on Surveillance of Severe Influenza Hospitalized Cases in Catalonia

Abstract readObservational Study
In one paragraph

Observational study in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Disparities in Seasonal Influenza Vaccination in Europe.Immunity, inflammation and disease · 2025
    Review
  4. Article
  5. Hospitalisation trends of respiratory syncytial virus (RSV) infection in adults, six European countries, before and during COVID-19, 2016 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. [Expert opinion on strategies to improve vaccination coverage against seasonal influenza].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pere GodoyAgència de Salut Pública de Catalunya, Barcelona, Spain.
Arantxa RomeroCIBER Epidemiología y Salud Pública, Barcelona, Spain.
Núria SoldevilaCIBER Epidemiología y Salud Pública, Barcelona, Spain.
Nuria TornerAgència de Salut Pública de Catalunya, Barcelona, Spain.
Mireia JanéAgència de Salut Pública de Catalunya, Barcelona, Spain.
Ana MartínezAgència de Salut Pública de Catalunya, Barcelona, Spain.
Joan A CaylàTB Research Unit Foundation (fuiTB), Barcelona, Spain.
Cristina RiusCIBER Epidemiología y Salud Pública, Barcelona, Spain.
Angela DomínguezCIBER Epidemiología y Salud Pública, Barcelona, Spain.
Working Group on Surveillance of Severe Influenza Hospitalized Cases in CataloniaThe Working Group on Surveillance of Severe Influenza Hospitalized Cases in Catalonia have been listed at the end of this article.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Population SurveillanceVaccine PotencyAdolescentAdultAgedAged, 80 and overCase-Control StudiesFemaleHospitalizationHospital MortalityHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza, HumanInfluenza VaccinesMaleInfluenza Vaccinesdisease severityhospitalised patientsinfluenzaSpainvaccine effectiveness

Identifiers

PMID30376915
PMCPMC6208006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.